Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections

BACKGROUND: Immunotherapy is a promising prospective new treatment for cytomegalovirus (CMV) infections. Neutralizing effects have been reported using monoclonal antibodies. Recombinant single chain antibodies (scFvs) due to their advantages over monoclonal antibodies are potential alternatives and...

Descripción completa

Detalles Bibliográficos
Autores principales: Moazen, Bahareh, Ebrahimi, Elahe, Nejatollahi, Foroogh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870390/
https://www.ncbi.nlm.nih.gov/pubmed/27217918
http://dx.doi.org/10.5812/jjm.16241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870390/
https://www.ncbi.nlm.nih.gov/pubmed/27217918
http://dx.doi.org/10.5812/jjm.16241

Ejemplares similares